These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 7904743)

  • 1. Fibroblast growth factor mediated alterations in drug resistance, and evidence of gene amplification.
    Huang A; Wright JA
    Oncogene; 1994 Feb; 9(2):491-9. PubMed ID: 7904743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of the 18 kDa and 22/24 kDa FGF-2 isoforms results in differential drug resistance and amplification potential.
    Dini G; Funghini S; Witort E; Magnelli L; Fanti E; Rifkin DB; Del Rosso M
    J Cell Physiol; 2002 Oct; 193(1):64-72. PubMed ID: 12209881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant expression of basic fibroblast growth factor in NIH-3T3 cells alters drug resistance and gene amplification potential.
    Huang A; Jin H; Wright JA
    Exp Cell Res; 1994 Aug; 213(2):335-9. PubMed ID: 8050490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The propensity for gene amplification: a comparison of protocols, cell lines, and selection agents.
    Sharma RC; Schimke RT
    Mutat Res; 1994 Jan; 304(2):243-60. PubMed ID: 7506368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple mechanisms of N-phosphonacetyl-L-aspartate resistance in human cell lines: carbamyl-P synthetase/aspartate transcarbamylase/dihydro-orotase gene amplification is frequent only when chromosome 2 is rearranged.
    Smith KA; Chernova OB; Groves RP; Stark MB; Martínez JL; Davidson JN; Trent JM; Patterson TE; Agarwal A; Duncan P; Agarwal ML; Stark GR
    Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1816-21. PubMed ID: 9050862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The presence of amplified regions affects the stability of chromosomes in drug-resistant Chinese hamster cells.
    Miele M; Bonatti S; Menichini P; Ottaggio L; Abbondandolo A
    Mutat Res; 1989 May; 219(3):171-8. PubMed ID: 2567961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MYC abrogates p53-mediated cell cycle arrest in N-(phosphonacetyl)-L-aspartate-treated cells, permitting CAD gene amplification.
    Chernova OB; Chernov MV; Ishizaka Y; Agarwal ML; Stark GR
    Mol Cell Biol; 1998 Jan; 18(1):536-45. PubMed ID: 9418900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of CAD gene amplification by restriction endonucleases in V79,B7 Chinese hamster cells.
    Cavolina P; Agnese C; Maddalena A; Sciandrello G; Di Leonardo A
    Mutat Res; 1989; 225(1-2):61-4. PubMed ID: 2563307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ribonucleotide reductase R2 gene expression and changes in drug sensitivity and genome stability.
    Huang A; Fan H; Taylor WR; Wright JA
    Cancer Res; 1997 Nov; 57(21):4876-81. PubMed ID: 9354452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late onset of CAD gene amplification in unamplified PALA resistant Chinese hamster mutants.
    Mucciolo E; Bertoni L; Mondello C; Giulotto E
    Cancer Lett; 2000 Mar; 150(2):119-27. PubMed ID: 10704733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumorigenicity and gene amplification potentials of cyclin D1-overexpressing NIH3T3 cells.
    Asano K; Sakamoto H; Sasaki H; Ochiya T; Yoshida T; Ohishi Y; Machida T; Kakizoe T; Sugimura T; Terada M
    Biochem Biophys Res Commun; 1995 Dec; 217(3):1169-76. PubMed ID: 8554573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1-beta-D-arabinofuranosylcytosine enhancement of resistance to several antineoplastic drugs in mammalian tissue culture cells.
    Goz B; Carl PL; Tlsty TD
    Mol Pharmacol; 1989 Sep; 36(3):360-5. PubMed ID: 2571071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxyurea accelerates loss of extrachromosomally amplified genes from tumor cells.
    Von Hoff DD; Waddelow T; Forseth B; Davidson K; Scott J; Wahl G
    Cancer Res; 1991 Dec; 51(23 Pt 1):6273-9. PubMed ID: 1682044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug resistance and gene amplification potential regulated by transforming growth factor beta 1 gene expression.
    Huang A; Jin H; Wright JA
    Cancer Res; 1995 Apr; 55(8):1758-62. PubMed ID: 7712485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased gene amplification in immortal rodent cells deficient for the DNA-dependent protein kinase catalytic subunit.
    Mondello C; Rebuzzini P; Dolzan M; Edmonson S; Taccioli GE; Giulotto E
    Cancer Res; 2001 Jun; 61(11):4520-5. PubMed ID: 11389084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of chromosomal integrity in neoplasia.
    Tlsty TD; Jonczyk P; White A; Sage M; Hall I; Schaefer D; Briot A; Livanos E; Roelofs H; Poulose B
    Cold Spring Harb Symp Quant Biol; 1993; 58():645-54. PubMed ID: 7956081
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of gene amplification in telomerase deficient immortalized mouse embryonic fibroblasts.
    Rebuzzini P; Martinelli P; Blasco M; Giulotto E; Mondello C
    Carcinogenesis; 2007 Mar; 28(3):553-9. PubMed ID: 16973670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New mechanisms of gene amplification in drug resistance (the episome model).
    Von Hoff DD
    Cancer Treat Res; 1991; 57():1-11. PubMed ID: 1686710
    [No Abstract]   [Full Text] [Related]  

  • 19. Gene amplification and gene deletion are induced at different rates in V79/AP4 Chinese hamster cells.
    Vatteroni L; Piras A; Moretti A; Rainaldi G
    Mutagenesis; 1993 Sep; 8(5):411-5. PubMed ID: 7901735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosome aberrations associated with CAD gene amplification in Chinese hamster cultured cells.
    Ottaggio L; Agnese C; Bonatti S; Cavolina P; De Ambrosis A; Degan P; Di Leonardo A; Miele M; Randazzo R; Abbondandolo A
    Mutat Res; 1988 May; 199(1):111-21. PubMed ID: 2896299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.